Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 03, 2015 4:26 AM ET

Life Sciences Tools and Services

Company Overview of MaRS Innovation

Company Overview

MaRS Innovation operates as a commercialization agent for the intellectual properties in the areas of therapeutics, medical device, diagnostic imaging, information, communications, and manufacturing and clean technologies to the inventors in Canada. The company has strategic partnerships with GlaxoSmithKline Inc.; CML HealthCare Inc.; Baxter International Inc.; and Pfizer Inc. MaRS Innovation was incorporated in 2008 and is based in Toronto, Canada.

101 College Street

MaRS Centre

South Tower

Suite 402

Toronto, ON M5G 1L7


Founded in 2008



Key Executives for MaRS Innovation

Chief Executive Officer, President and Director
Age: 66
Chief Financial Officer and Director
Secretary, Executive Assistant of Chief Executive Officer, Executive Assistant of President and Director
Director of Human Resources
Director of Commercialization
Compensation as of Fiscal Year 2015.

MaRS Innovation Key Developments

Encycle Therapeutics Inc. Announces Partnership with MaRS Innovation to Develop Molecule to Tackle Inflammatory Bowel Disease

Encycle Therapeutics Inc. in partnership with MaRS Innovation which is involved in the inflammatory process in a number of diseases, most notably for inflammatory bowel disease. To support and advance this molecule, Encycle Therapeutics is collaboratively partnering with the Institute for Research in Immunology and Cancer - Commercialization of Research (IRICoR), the Université de Montréal (UdeM) and MaRS Innovation. The agreement brings a significant investment to fund Encycle Therapeutics' development work, giving IRICoR an equity position and expanding MaRS Innovation's equity stake. Cumulatively, Encycle Therapeutics has secured more than $2.5 million to advance its drug development platform. The partnership will fund and deploy a number of experienced medicinal chemists at UdeM's Institute for Research in Immunology and Cancer (IRIC) to optimize Encycle Therapeutics' lead molecule. Additional studies will be conducted at the biopharmacy platform of the Faculty of Pharmacy of the UdeM, while Encycle Therapeutics conducts other project-related activities, including pre-clinical efficacy studies.

Johnson & Johnson Innovation, Janssen Inc. Announce New Collaborations with NEOMED and MaRS Innovation

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health. Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

MaRS Innovation Presents at BioJapan 2013 World Business Forum, Oct-09-2013

MaRS Innovation Presents at BioJapan 2013 World Business Forum, Oct-09-2013 . Venue: Pacifico Yokohama, Yokohama, Japan.

Similar Private Companies By Industry

Company Name Region
Acclaim Pharma Research, Inc. Americas
MedQualis Inc. Americas
Warnex Inc. Americas
KMT Hepatech Inc. Americas
Biovar Life Support, Inc. Americas

Recent Private Companies Transactions

Private Placement
March 3, 2015
ChipCare Corporation
Private Placement
September 29, 2014
Formation Biologics Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MaRS Innovation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at